Role and Function of O-GlcNAcylation in Cancer

Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or incre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2021-10, Vol.13 (21), p.5365
Hauptverfasser: Lee, Jii Bum, Pyo, Kyoung-Ho, Kim, Hye Ryun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 21
container_start_page 5365
container_title Cancers
container_volume 13
creator Lee, Jii Bum
Pyo, Kyoung-Ho
Kim, Hye Ryun
description Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism.
doi_str_mv 10.3390/cancers13215365
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8582477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2596009059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-6a0cf5ed7a789188784f18a195f78861a1e39b22670904ace86340eef23170633</originalsourceid><addsrcrecordid>eNpdkctLAzEQxoMottSevS548bJtHpvXRSjFVqFYED2HNJvVLdukJrtC_3vTB6KdywwzP775hgHgFsERIRKOjXbGhogIRpQwegH6GHKcMyaLyz91DwxjXMMUhCDO-DXokYJzRDHvg9Grb2ymXZnNOmfa2rvMV9kynzfmZWJ2jT60apdND8tuwFWlm2iHpzwA77PHt-lTvljOn6eTRW6IFG3ONDQVtSXXXEgkBBdFhYRGklZcCIY0skSuMGYcSlhoYwUjBbS2wskhZIQMwMNRd9utNrY01rVBN2ob6o0OO-V1rf5PXP2pPvy3ElTgdFwSuD8JBP_V2diqTR2NbRrtrO-iwlTyQtLkLaF3Z-jad8Gl8_YUg8kilYkaHykTfIzBVr9mEFT7d6izd5AfH_56hg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596009059</pqid></control><display><type>article</type><title>Role and Function of O-GlcNAcylation in Cancer</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Lee, Jii Bum ; Pyo, Kyoung-Ho ; Kim, Hye Ryun</creator><creatorcontrib>Lee, Jii Bum ; Pyo, Kyoung-Ho ; Kim, Hye Ryun</creatorcontrib><description>Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13215365</identifier><identifier>PMID: 34771527</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Aerobic conditions ; Angiogenesis ; Cancer ; Cell activation ; Cell differentiation ; Cell proliferation ; Cellular stress response ; Chemotherapy ; Cisplatin ; DNA methylation ; Energy metabolism ; Enzymes ; Gene expression ; Glucose ; Glucose metabolism ; Glycolysis ; Homeostasis ; Hypotheses ; Immunosurveillance ; Immunotherapy ; Insulin ; Kinases ; Lymphocytes T ; Macrophages ; Metabolism ; Metastases ; Metastasis ; N-Acetylglucosamine ; Nutrients ; O-GlcNAcylation ; Phosphorylation ; Polypeptides ; Protein-tyrosine kinase receptors ; Proteins ; Review ; RNA polymerase ; Signal transduction ; Tumor cells ; Tumor microenvironment</subject><ispartof>Cancers, 2021-10, Vol.13 (21), p.5365</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-6a0cf5ed7a789188784f18a195f78861a1e39b22670904ace86340eef23170633</citedby><cites>FETCH-LOGICAL-c398t-6a0cf5ed7a789188784f18a195f78861a1e39b22670904ace86340eef23170633</cites><orcidid>0000-0001-5608-3157</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582477/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582477/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Lee, Jii Bum</creatorcontrib><creatorcontrib>Pyo, Kyoung-Ho</creatorcontrib><creatorcontrib>Kim, Hye Ryun</creatorcontrib><title>Role and Function of O-GlcNAcylation in Cancer</title><title>Cancers</title><description>Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism.</description><subject>Aerobic conditions</subject><subject>Angiogenesis</subject><subject>Cancer</subject><subject>Cell activation</subject><subject>Cell differentiation</subject><subject>Cell proliferation</subject><subject>Cellular stress response</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>DNA methylation</subject><subject>Energy metabolism</subject><subject>Enzymes</subject><subject>Gene expression</subject><subject>Glucose</subject><subject>Glucose metabolism</subject><subject>Glycolysis</subject><subject>Homeostasis</subject><subject>Hypotheses</subject><subject>Immunosurveillance</subject><subject>Immunotherapy</subject><subject>Insulin</subject><subject>Kinases</subject><subject>Lymphocytes T</subject><subject>Macrophages</subject><subject>Metabolism</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>N-Acetylglucosamine</subject><subject>Nutrients</subject><subject>O-GlcNAcylation</subject><subject>Phosphorylation</subject><subject>Polypeptides</subject><subject>Protein-tyrosine kinase receptors</subject><subject>Proteins</subject><subject>Review</subject><subject>RNA polymerase</subject><subject>Signal transduction</subject><subject>Tumor cells</subject><subject>Tumor microenvironment</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkctLAzEQxoMottSevS548bJtHpvXRSjFVqFYED2HNJvVLdukJrtC_3vTB6KdywwzP775hgHgFsERIRKOjXbGhogIRpQwegH6GHKcMyaLyz91DwxjXMMUhCDO-DXokYJzRDHvg9Grb2ymXZnNOmfa2rvMV9kynzfmZWJ2jT60apdND8tuwFWlm2iHpzwA77PHt-lTvljOn6eTRW6IFG3ONDQVtSXXXEgkBBdFhYRGklZcCIY0skSuMGYcSlhoYwUjBbS2wskhZIQMwMNRd9utNrY01rVBN2ob6o0OO-V1rf5PXP2pPvy3ElTgdFwSuD8JBP_V2diqTR2NbRrtrO-iwlTyQtLkLaF3Z-jad8Gl8_YUg8kilYkaHykTfIzBVr9mEFT7d6izd5AfH_56hg</recordid><startdate>20211026</startdate><enddate>20211026</enddate><creator>Lee, Jii Bum</creator><creator>Pyo, Kyoung-Ho</creator><creator>Kim, Hye Ryun</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5608-3157</orcidid></search><sort><creationdate>20211026</creationdate><title>Role and Function of O-GlcNAcylation in Cancer</title><author>Lee, Jii Bum ; Pyo, Kyoung-Ho ; Kim, Hye Ryun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-6a0cf5ed7a789188784f18a195f78861a1e39b22670904ace86340eef23170633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aerobic conditions</topic><topic>Angiogenesis</topic><topic>Cancer</topic><topic>Cell activation</topic><topic>Cell differentiation</topic><topic>Cell proliferation</topic><topic>Cellular stress response</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>DNA methylation</topic><topic>Energy metabolism</topic><topic>Enzymes</topic><topic>Gene expression</topic><topic>Glucose</topic><topic>Glucose metabolism</topic><topic>Glycolysis</topic><topic>Homeostasis</topic><topic>Hypotheses</topic><topic>Immunosurveillance</topic><topic>Immunotherapy</topic><topic>Insulin</topic><topic>Kinases</topic><topic>Lymphocytes T</topic><topic>Macrophages</topic><topic>Metabolism</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>N-Acetylglucosamine</topic><topic>Nutrients</topic><topic>O-GlcNAcylation</topic><topic>Phosphorylation</topic><topic>Polypeptides</topic><topic>Protein-tyrosine kinase receptors</topic><topic>Proteins</topic><topic>Review</topic><topic>RNA polymerase</topic><topic>Signal transduction</topic><topic>Tumor cells</topic><topic>Tumor microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Jii Bum</creatorcontrib><creatorcontrib>Pyo, Kyoung-Ho</creatorcontrib><creatorcontrib>Kim, Hye Ryun</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Jii Bum</au><au>Pyo, Kyoung-Ho</au><au>Kim, Hye Ryun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role and Function of O-GlcNAcylation in Cancer</atitle><jtitle>Cancers</jtitle><date>2021-10-26</date><risdate>2021</risdate><volume>13</volume><issue>21</issue><spage>5365</spage><pages>5365-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34771527</pmid><doi>10.3390/cancers13215365</doi><orcidid>https://orcid.org/0000-0001-5608-3157</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2021-10, Vol.13 (21), p.5365
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8582477
source MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Aerobic conditions
Angiogenesis
Cancer
Cell activation
Cell differentiation
Cell proliferation
Cellular stress response
Chemotherapy
Cisplatin
DNA methylation
Energy metabolism
Enzymes
Gene expression
Glucose
Glucose metabolism
Glycolysis
Homeostasis
Hypotheses
Immunosurveillance
Immunotherapy
Insulin
Kinases
Lymphocytes T
Macrophages
Metabolism
Metastases
Metastasis
N-Acetylglucosamine
Nutrients
O-GlcNAcylation
Phosphorylation
Polypeptides
Protein-tyrosine kinase receptors
Proteins
Review
RNA polymerase
Signal transduction
Tumor cells
Tumor microenvironment
title Role and Function of O-GlcNAcylation in Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T09%3A51%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20and%20Function%20of%20O-GlcNAcylation%20in%20Cancer&rft.jtitle=Cancers&rft.au=Lee,%20Jii%20Bum&rft.date=2021-10-26&rft.volume=13&rft.issue=21&rft.spage=5365&rft.pages=5365-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13215365&rft_dat=%3Cproquest_pubme%3E2596009059%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596009059&rft_id=info:pmid/34771527&rfr_iscdi=true